Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Porst

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The Journal of Sexual Medicine|August 14, 2010
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)Jacques Buvat, Francesco Montorsi, Mario Maggi, et al.
European Urology|February 5, 2013
Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptomsClaudius Füllhase, Christopher Chapple, Jean-Nicolas Cornu, et al.
BJU International|July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in MenFrans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
BJU International|May 24, 2008
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature EjaculationChris G McMahon, Stanley Althof, Marcel D Waldinger, et al.
The Journal of Sexual Medicine|May 10, 2008
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculationChris G McMahon, Stanley E Althof, Marcel D Waldinger, et al.
The Journal of Sexual Medicine|January 21, 2006
Pharmacotherapy for erectile dysfunctionHarin Padma-Nathan, George Christ, Ganesan Adaikan, et al.
The Journal of Sexual Medicine|August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
The Journal of Sexual Medicine|November 6, 2010
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculationStanley E Althof, Carmita H N Abdo, John Dean, et al.
The Journal of Sexual Medicine|November 3, 2010
Summary of the recommendations on sexual dysfunctions in menFrancesco Montorsi, Ganesan Adaikan, Edgardo Becher, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Journal of Sexual Medicine|August 14, 2010
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)Jacques Buvat, Francesco Montorsi, Mario Maggi, et al.
European Urology|February 5, 2013
Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptomsClaudius Füllhase, Christopher Chapple, Jean-Nicolas Cornu, et al.
BJU International|July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in MenFrans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
BJU International|May 24, 2008
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature EjaculationChris G McMahon, Stanley Althof, Marcel D Waldinger, et al.
The Journal of Sexual Medicine|May 10, 2008
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculationChris G McMahon, Stanley E Althof, Marcel D Waldinger, et al.
The Journal of Sexual Medicine|January 21, 2006
Pharmacotherapy for erectile dysfunctionHarin Padma-Nathan, George Christ, Ganesan Adaikan, et al.
The Journal of Sexual Medicine|August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
The Journal of Sexual Medicine|November 6, 2010
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculationStanley E Althof, Carmita H N Abdo, John Dean, et al.
The Journal of Sexual Medicine|November 3, 2010
Summary of the recommendations on sexual dysfunctions in menFrancesco Montorsi, Ganesan Adaikan, Edgardo Becher, et al.
Pageof 7